Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma?

Ramiro J. Méndez, Ángel Nava

Open source

DOI
10.1148/rycan.260534
Published
2026-09-01
Container
Radiology: Imaging Cancer
Publisher
Radiological Society of North America (RSNA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1148/rycan.260534,
  title = {Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma?},
  author = {Ramiro J. Méndez and Ángel Nava},
  year = {2026},
  journal = {Radiology: Imaging Cancer},
  doi = {10.1148/rycan.260534},
  url = {https://doi.org/10.1148/rycan.260534}
}

RIS

TY  - JOUR
TI  - Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma?
AU  - Ramiro J. Méndez
AU  - Ángel Nava
PY  - 2026
JO  - Radiology: Imaging Cancer
DO  - 10.1148/rycan.260534
UR  - https://doi.org/10.1148/rycan.260534
ER  - 

APA

Méndez, R. J., & Nava, Á. (2026). Can Spectral CT Complement Biopsy for MSI/dMMR Assessment in Esophagogastric Junction Adenocarcinoma?. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.260534

Source records